03 May 2021

Our first 100 employees

This week Human Technopole reaches an important milestone: our first 100 employees have been recruited! In a little over a year we have grown from a staff of less than 30 people to 100, and counting. Our numbers continue to increase with new colleagues joining us every week from all over the world. 

Our employees reflect our organisation’s values of diversity and internationality. Among research personnel almost 70% of those joining HT are relocating to Italy from abroad and our overall staff counts 12 different nationalities. Ten out of 26 managerial positions in both administrative and scientific areas are in the hands of women which make up 44% of our workforce. 

If you are a passionate person who likes to seize great challenges, consider applying for one of our vacancies to help us build Human Technopole. All employees are selected through transparent and meritocratic selection processes to identify the best candidate for each position. All open positions are regularly published on our Careers page.

Share:

  • Facebook
  • Twitter
  • LinkedIn
  • Email

You could also like:

  • Colorectal Cancer: ML Enhances Cetuximab Response Predictions

    An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.

  • Human Technopole Foundation’s Supplier List online

    The Human Technopole Foundation’s Supplier Register is now online.

  • HT Director Zerial Awarded Mercurio Prize for Excellence in Research

    The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.

  • A polarized cortical assembly showing a spatial gradient of expression along its longitudinal axis (from left to right, colors from blue to yellow-red). @Camilla Bosone (IMBA)

    A new model system for cortical development in vitro

    Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.

  • The National Facility for Genomics with Clelia Peano

    Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.